Characterization of a new SARS-CoV-2 variant that emerged in BrazilMasaki Imai, Tsuguto Fujimoto, Noriko Nakajima et al.|Proceedings of the National Academy of Sciences|2021Cited by 87
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2Yoshihiro Kawaoka, Tadaki Suzuki, Ryuta Uraki et al.|Research Square|2022Cited by 41
Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster ModelS. Chiba, Yoshihiro Kawaoka, Maki Kiso et al.|mBio|2022Cited by 32